Insmed(美国)

Insmed

Insmedwww.insmed.comInsmed是一家生物制药上市公司。Insmed拥有为肺提供独特的liposomal吸入式给药专利技术。InsmedIncorporatedisabiopharmaceuticalcompanydedicatedtoimprovingthelivesofpatientsbattlingseriouslungdiseasesthroughthedevelopm entandcommercializationofinhalationtherapiesinorphanpatientpopulationswithcriticalunmetneeds.Insmed'sleadcandidate,ARIKACE®orliposomalamikacinforinhalation,isengineeredtodeliveraprovenandpotentanti-infectivedirectlytothesiteofseriouslunginfectionstoimprovetheefficacy,safetyandconvenienceoftreatmentforatleasttwoidentifiedpatientpopulations:cysticfibrosis(CF)patientswithPseudomonasaeruginosalunginfectionsandpatientswithnon-tuberculousmycobacterialunginfections(NTM).Insmed'sphase3registrationalstudyofARIKACEinEuropeandCanadacompletedenrollmentandtheCompanyexpectstop-lineclinicalresultsinmid-2013.Insmed'sphase2clinicaltrialinpatientswithNTM